|
2025-04-18 |
2025-04-16 |
S
Sale
|
Cedron Jorge Andres
CLO
Officer
|
1,000
-8.2%
13.31
USD 50,791
|
1,000
-8.2%
|
13.31
|
USD 100,000
|
|
|
2025-04-04 |
2025-04-02 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
76
-0.2%
15.74
USD 1,196
|
76
-0.2%
|
15.74
|
USD 1,196
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
296
-0.7%
16.60
USD 4,914
|
296
-0.7%
|
16.60
|
USD 4,914
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Vitale Lucas
CP&BOO
Officer
|
4,287
-3.1%
16.60
USD 71,164
|
4,287
-3.1%
|
16.60
|
USD 71,164
|
|
|
2025-03-06 |
2025-03-05 |
B
Purchase
|
Calafiore Massimo
President & CEO
Executive Director
|
9,914
+4.7%
17.43
USD 172,801
|
9,914
+4.7%
|
17.43
|
USD 172,801
|
|
|
2025-02-05 |
2025-02-04 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
187
-0.5%
18.08
USD 3,381
|
187
-0.5%
|
18.08
|
USD 3,381
|
|
|
2025-02-05 |
2025-02-03 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
767
-1.9%
17.79
USD 13,645
|
767
-1.9%
|
17.79
|
USD 13,645
|
|
|
2025-01-21 |
2025-01-16 |
S
Sale
|
Andrews Julie
CFO
Officer
|
4,655
-14.1%
17.89
USD 83,278
|
4,655
-14.1%
|
17.89
|
USD 83,278
|
|
|
2025-01-14 |
2025-01-13 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
227
-0.6%
17.14
USD 3,891
|
227
-0.6%
|
17.14
|
USD 3,891
|
|
|
2025-01-14 |
2025-01-13 |
S
Sale
|
Calafiore Massimo
President & CEO
Executive Director
|
9,203
-6.9%
17.14
USD 157,757
|
9,203
-6.9%
|
17.14
|
USD 157,757
|
|
|
2025-01-14 |
2025-01-10 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
248
-0.6%
16.83
USD 4,174
|
248
-0.6%
|
16.83
|
USD 4,174
|
|
|
2025-01-14 |
2025-01-10 |
S
Sale
|
Calafiore Massimo
President & CEO
Executive Director
|
10,078
-7.0%
16.83
USD 169,619
|
10,078
-7.0%
|
16.83
|
USD 169,619
|
|
|
2025-01-10 |
2025-01-08 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
238
-0.6%
16.97
USD 4,039
|
238
-0.6%
|
16.97
|
USD 4,039
|
|
|
2025-01-10 |
2025-01-07 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
238
-0.6%
17.14
USD 4,078
|
238
-0.6%
|
17.14
|
USD 4,078
|
|
|
2024-12-19 |
2024-12-17 |
S
Sale
|
Gillespie Geoffrey C
CAO
Officer
|
26
-0.1%
17.84
USD 464
|
26
-0.1%
|
17.84
|
USD 464
|
|
|
2023-09-14 |
2023-09-14 |
B
Purchase
|
Hinrichs James F.
Non-Executive Director
|
7,500
+9.5%
13.47
USD 101,025
|
7,500
+9.5%
|
13.47
|
USD 101,025
|
|
|
2023-05-26 |
2023-05-26 |
S
Sale
|
Kenny Kevin J.
President of Global Spine
Officer
|
3,876
-2.6%
19.00
USD 73,644
|
3,876
-2.6%
|
19.00
|
USD 73,644
|
|
|
2023-05-26 |
2023-05-24 |
S
Sale
|
Kenny Kevin J.
President of Global Spine
Officer
|
4,367
-2.9%
19.00
USD 82,973
|
4,367
-2.9%
|
19.00
|
USD 82,973
|
|
|
2023-04-05 |
2023-03-10 |
S
Sale
|
Maniar Shweta
Non-Executive Director
|
4,262
-17.5%
17.75
USD 75,651
|
4,262
-17.5%
|
17.75
|
USD 75,651
|
|
|
2021-11-22 |
2021-11-22 |
B
Purchase
|
Paolucci Michael E
Non-Executive Director
|
2,000
+8.0%
31.15
USD 62,300
|
2,000
+8.0%
|
31.15
|
USD 62,300
|
|
|
2021-11-19 |
2021-11-19 |
B
Purchase
|
BURZIK CATHERINE M
Non-Executive Director
|
1,660
+26.4%
30.27
USD 50,248
|
1,660
+26.4%
|
30.27
|
USD 50,248
|
|
|
2021-11-19 |
2021-11-19 |
B
Purchase
|
DOUG RICE
CFO
Officer
|
1,400
+1.9%
30.05
USD 42,070
|
1,400
+1.9%
|
30.05
|
USD 42,070
|
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
Elting Kimberley A.
Chief Legal & Develop. Officer
Officer
|
1,000
+2.2%
30.34
USD 30,340
|
1,000
+2.2%
|
30.34
|
USD 30,340
|
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
Serbousek Jon Carl
CEO
Executive Director
|
1,670
+1.5%
31.14
USD 52,004
|
1,670
+1.5%
|
31.14
|
USD 52,004
|
|
|
2020-06-09 |
2020-06-05 |
S
Sale
|
Finegan Michael
Chief Strategy Officer
Officer
|
8,750
-15.4%
37.41
USD 327,323
|
8,750
-15.4%
|
37.41
|
USD 327,323
|
|
|
2020-03-18 |
2020-03-16 |
B
Purchase
|
MATRICARIA RONALD A
Non-Executive Director
|
20,000
+14.8%
24.25
USD 485,000
|
20,000
+14.8%
|
24.25
|
USD 485,000
|
|
|
2020-03-16 |
2020-03-12 |
B
Purchase
|
Hinrichs James F.
Non-Executive Director
|
10,000
+28.1%
26.85
USD 268,469
|
10,000
+28.1%
|
26.85
|
USD 268,469
|
|
|
2020-03-02 |
2020-02-27 |
B
Purchase
|
Serbousek Jon Carl
CEO
Executive Director
|
2,900
+7.5%
35.48
USD 102,895
|
2,900
+7.5%
|
35.48
|
USD 102,895
|
|
|
2019-11-04 |
2019-10-31 |
B
Purchase
|
MATRICARIA RONALD A
Non-Executive Director
|
100
+0.1%
42.30
USD 4,230
|
100
+0.1%
|
42.30
|
USD 4,230
|
|
|
2019-11-04 |
2019-10-31 |
B
Purchase
|
MATRICARIA RONALD A
Non-Executive Director
|
200
+0.1%
42.28
USD 8,455
|
200
+0.1%
|
42.28
|
USD 8,455
|
|
|
2019-11-04 |
2019-10-31 |
B
Purchase
|
MATRICARIA RONALD A
Non-Executive Director
|
19,700
+17.3%
42.27
USD 832,621
|
19,700
+17.3%
|
42.27
|
USD 832,621
|
|
|
2019-08-29 |
2019-08-28 |
S
Sale
|
Mason Brad
CEO
Executive Director
|
5,805
-3.4%
50.97
USD 295,874
|
5,805
-3.4%
|
50.97
|
USD 295,874
|
|
|
2019-06-17 |
2019-06-13 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
3,123
-2.0%
51.44
USD 160,638
|
3,123
-2.0%
|
51.44
|
USD 160,638
|
|
|
2019-06-17 |
2019-06-13 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
5,767
-3.5%
50.93
USD 293,689
|
5,767
-3.5%
|
50.93
|
USD 293,689
|
|
|
2019-05-16 |
2019-05-14 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
300
-0.2%
54.41
USD 16,324
|
300
-0.2%
|
54.41
|
USD 16,324
|
|
|
2019-05-16 |
2019-05-14 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
10,368
-5.9%
53.69
USD 556,638
|
10,368
-5.9%
|
53.69
|
USD 556,638
|
|
|
2019-04-19 |
2019-04-17 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
3,749
-2.1%
52.52
USD 196,897
|
3,749
-2.1%
|
52.52
|
USD 196,897
|
|
|
2019-04-19 |
2019-04-17 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
2,200
-1.2%
52.07
USD 114,547
|
2,200
-1.2%
|
52.07
|
USD 114,547
|
|
|
2019-02-20 |
2019-02-19 |
PS
Planned sale
|
Bianchi Davide
President, Global Extremities
Officer
|
24,199
-53.9%
65.00
USD 1,572,935
|
24,199
-53.9%
|
65.00
|
USD 1,572,935
|
|
|
2019-02-20 |
2019-02-15 |
PS
Planned sale
|
Bianchi Davide
President, Global Extremities
Officer
|
201
-0.4%
65.00
USD 13,065
|
201
-0.4%
|
65.00
|
USD 13,065
|
|
|
2019-01-16 |
2019-01-15 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
3,200
-2.3%
50.00
USD 160,000
|
3,200
-2.3%
|
50.00
|
USD 160,000
|
|
|
2019-01-16 |
2019-01-14 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
1,800
-1.3%
50.37
USD 90,665
|
1,800
-1.3%
|
50.37
|
USD 90,665
|
|
|
2018-11-06 |
2018-11-05 |
PS
Planned sale
|
NIEMANN BRADLEY V.
President of Global Spine
Officer
|
387
-1.5%
61.63
USD 23,851
|
387
-1.5%
|
61.63
|
USD 23,851
|
|
|
2018-11-06 |
2018-11-02 |
S
Sale
|
Elting Kimberley A.
Chief Legal & Admin Officer
Officer
|
7,000
-30.8%
61.05
USD 427,337
|
7,000
-30.8%
|
61.05
|
USD 427,337
|
|
|
2018-11-06 |
2018-11-02 |
PS
Planned sale
|
DOUG RICE
CFO
Officer
|
200
-0.8%
61.84
USD 12,368
|
200
-0.8%
|
61.84
|
USD 12,368
|
|
|
2018-11-06 |
2018-11-02 |
PS
Planned sale
|
DOUG RICE
CFO
Officer
|
5,857
-18.1%
61.23
USD 358,636
|
5,857
-18.1%
|
61.23
|
USD 358,636
|
|
|
2018-11-06 |
2018-11-02 |
S
Sale
|
FAULSTICK LUKE T
Non-Executive Director
|
700
-9.8%
61.74
USD 43,215
|
700
-9.8%
|
61.74
|
USD 43,215
|
|
|
2018-11-06 |
2018-11-02 |
S
Sale
|
FAULSTICK LUKE T
Non-Executive Director
|
3,600
-33.4%
60.93
USD 219,330
|
3,600
-33.4%
|
60.93
|
USD 219,330
|
|
|
2018-11-06 |
2018-11-02 |
S
Sale
|
FAULSTICK LUKE T
Non-Executive Director
|
650
-9.1%
61.72
USD 40,121
|
650
-9.1%
|
61.72
|
USD 40,121
|
|
|
2018-11-06 |
2018-11-02 |
S
Sale
|
FAULSTICK LUKE T
Non-Executive Director
|
3,500
-32.9%
60.93
USD 213,245
|
3,500
-32.9%
|
60.93
|
USD 213,245
|
|
|
2018-10-15 |
2018-10-11 |
PS
Planned sale
|
DOUG RICE
CFO
Officer
|
3,949
-10.9%
55.65
USD 219,754
|
3,949
-10.9%
|
55.65
|
USD 219,754
|
|
|
2018-09-07 |
2018-09-05 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
2,500
-1.7%
53.02
USD 132,555
|
2,500
-1.7%
|
53.02
|
USD 132,555
|
|
|
2018-08-09 |
2018-08-07 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
300
-0.2%
55.14
USD 16,543
|
300
-0.2%
|
55.14
|
USD 16,543
|
|
|
2018-08-09 |
2018-08-07 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
500
-0.3%
53.95
USD 26,977
|
500
-0.3%
|
53.95
|
USD 26,977
|
|
|
2018-08-09 |
2018-08-07 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
1,400
-0.9%
53.02
USD 74,225
|
1,400
-0.9%
|
53.02
|
USD 74,225
|
|
|
2018-08-09 |
2018-08-07 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
300
-0.2%
51.41
USD 15,423
|
300
-0.2%
|
51.41
|
USD 15,423
|
|
|
2018-07-11 |
2018-07-10 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
2,500
-1.8%
58.62
USD 146,554
|
2,500
-1.8%
|
58.62
|
USD 146,554
|
|
|
2018-07-05 |
2018-07-03 |
S
Sale
|
NIEMANN BRADLEY V.
President of Global Spine
Officer
|
2,150
-7.4%
57.35
USD 123,309
|
2,150
-7.4%
|
57.35
|
USD 123,309
|
|
|
2018-07-05 |
2018-07-03 |
S
Sale
|
NIEMANN BRADLEY V.
President of Global Spine
Officer
|
9,100
-23.8%
56.94
USD 518,126
|
9,100
-23.8%
|
56.94
|
USD 518,126
|
|
|
2018-06-21 |
2018-06-20 |
PS
Planned sale
|
FUJIKAWA RAYMOND
President Spine Fixation
Officer
|
4,196
-24.6%
60.49
USD 253,833
|
4,196
-24.6%
|
60.49
|
USD 253,833
|
|
|
2018-06-21 |
2018-06-20 |
PS
Planned sale
|
FUJIKAWA RAYMOND
President Spine Fixation
Officer
|
28,047
-62.2%
60.16
USD 1,687,369
|
28,047
-62.2%
|
60.16
|
USD 1,687,369
|
|
|
2018-06-19 |
2018-06-19 |
PS
Planned sale
|
Bianchi Davide
President Extremity Fixation
Officer
|
14,762
-26.4%
60.00
USD 885,720
|
14,762
-26.4%
|
60.00
|
USD 885,720
|
|
|
2018-06-19 |
2018-06-18 |
PS
Planned sale
|
Finegan Michael
Chief Strategy Officer
Officer
|
10,725
-22.5%
59.13
USD 634,128
|
10,725
-22.5%
|
59.13
|
USD 634,128
|
|
|
2018-06-19 |
2018-06-18 |
PS
Planned sale
|
Finegan Michael
Chief Strategy Officer
Officer
|
19,275
-28.8%
58.63
USD 1,130,172
|
19,275
-28.8%
|
58.63
|
USD 1,130,172
|
|
|
2018-06-15 |
2018-06-14 |
PS
Planned sale
|
Mason Brad
CEO
Executive Director
|
2,500
-1.7%
57.95
USD 144,864
|
2,500
-1.7%
|
57.95
|
USD 144,864
|
|
|
2018-05-07 |
2018-05-03 |
B
Purchase
|
MATRICARIA RONALD A
Non-Executive Director
|
10,000
+10.9%
51.97
USD 519,724
|
10,000
+10.9%
|
51.97
|
USD 519,724
|
|
|
2017-12-13 |
2017-12-11 |
PS
Planned sale
|
NIEMANN BRADLEY V.
President Biostim
|
5,547
-13.8%
52.08
USD 288,861
|
5,547
-13.8%
|
52.08
|
USD 288,861
|
|
|
2017-11-30 |
2017-11-28 |
S
Sale
|
Mason Brad
CEO
Executive Director
|
5,000
-2.7%
53.48
USD 267,400
|
5,000
-2.7%
|
53.48
|
USD 267,400
|
|
|
2017-11-08 |
2017-11-06 |
S
Sale
|
FAULSTICK LUKE T
|
4,800
-38.3%
51.22
USD 245,846
|
4,800
-38.3%
|
51.22
|
USD 245,846
|
|
|
2017-09-13 |
2017-09-11 |
PS
Planned sale
|
NIEMANN BRADLEY V.
President Biostim
|
6,956
-14.8%
49.44
USD 343,926
|
6,956
-14.8%
|
49.44
|
USD 343,926
|
|
|
2017-09-13 |
2017-09-11 |
PS
Planned sale
|
DOUG RICE
CFO
|
7,353
-14.1%
49.46
USD 363,689
|
7,353
-14.1%
|
49.46
|
USD 363,689
|
|
|
2017-08-23 |
2017-08-21 |
S
Sale
|
Mason Brad
CEO
|
2,733
-1.4%
48.10
USD 131,457
|
2,733
-1.4%
|
48.10
|
USD 131,457
|
|
|
2017-08-14 |
2017-08-10 |
S
Sale
|
FUJIKAWA RAYMOND
President Spine Fixation
|
6,364
-17.0%
47.06
USD 299,502
|
6,364
-17.0%
|
47.06
|
USD 299,502
|
|
|
2016-11-10 |
2016-11-10 |
S
Sale
|
Mason Brad
CEO
Officer
|
4,538
-3.0%
36.84
USD 167,194
|
4,538
-3.0%
|
36.84
|
USD 167,194
|
|
|
2016-11-10 |
2016-11-08 |
S
Sale
|
Mason Brad
CEO
Officer
|
5,000
-3.2%
36.81
USD 184,073
|
5,000
-3.2%
|
36.81
|
USD 184,073
|
|
